July 6, 2020 Calyxt Announces Board Changes Dr. Andr&eaigu; Choulika decides to retire from Calyxt`s Board to fully focus on Cellectis development Yves Ribeill, Biotech Veteran and Member of Calyxt`s Board of Directors, to Chair the Board Laurent Arthaud designated by Cellectis and appointed as a Director ROSEVILLE, Minn.--(BUSINESS WIRE)-- Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced the appointment of current board member Yves Ribeill, Ph.D., as Chairman. This appointment coincides with Dr. Andr&eaigu; Choulika`s decision to wholly focus his energy on Cellectis` clinical development activities, and thus, retiring as Chairman of Calyxt`s Board. Additionally, Calyxt`s Board...
|
